Category: trial

academia, academic, agreement, analysis, analytics, benefit, business, Business Analysis, cannabis, clinical, Cultivation & Growing, data, extraction, Federal, government, growing, industry, innovation, lab, laboratories, Laboratories & Analytics, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicinal, medicine, Operations, preclinical, product, Product Development, Quality, regulation, regulations, regulatory, research, retail, safety, state, studies, Study, Technology, test, Testing, transfer, trial, universities, University

Is the Cannabis Industry Sitting On An Untouched Gold Mine Of Innovation?

Is the Cannabis Industry Sitting On An Untouched Gold Mine Of Innovation?

Universities across the country are working in all areas of research and development to advance cannabis cultivation, medicine, drug delivery and technology. […]

Affinity, analysis, analytics, bio, business, Business Analysis, cannabinoid, cannabis, Christina Diarcangelo, clinical, diabetic, drug, Federal, government, growing, head, industry, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, medical, medicine, nerve, pain, Partners, pharma, pharmaceutical, product, Product Development, Quality, regulation, regulatory, safety, state, studies, Study, test, Testing, therapeutics, to, trial, Zelira

First Pharma vs Cannabis Clinical Trial Moves Forward

First Pharma vs Cannabis Clinical Trial Moves Forward

Affinity Bio Partners on Working with Zelira Therapeutics to Complete Enrolment for Diabetic Nerve Pain Drug Trial It’s an exciting time in […]

1, analysis, analytics, and Cosmetics Act, application, approval, approve, business, Business Analysis, cannabidiol, cannabis, cbd, clinical, clinical trials, compliance, consumer packaged goods, CPG, CSA, dea, derived, deschedule, descheduled, Dravet syndrome, drug, Drug Enforcement Administration, Epidiolex, epilepsy, extraction, FDA, FDCA, Federal, Federal Food, FFDCA, food and drug administration, formulation, government, GW, GW Pharma, hemp, industry, law, legal, legalization, legalize, legislation, Lennox-Gastaut syndrome, license, marijuana, market, medical, medicine, New, patent, pathway, patient, pharma, pharmaceutical, product, Product Development, program, regulation, regulations, regulatory, REMS, safety, schedule, seizures, state, Substances, thc, trial, TSC

How GW Pharma Won CBD

How GW Pharma Won CBD

As of this writing, the United States Food and Drug Administration (FDA) has approved GW Pharma’s CBD drug Epidiolex for treating profound […]